Twin pregnancy outcome following teriflunomide treatment in a relapsing-remitting multiple sclerosis patient: A case report

RATIONALE: Teriflunomide is a disease-modifying drug that has been approved for treatment of relapsing-remitting multiple sclerosis. Due to its teratogenic effect in animals, however, it is not recommended during pregnancy. For this reason, effective contraception must be used during its administrat...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Aleo, Giangaetano, Rifici, Carmela, Donato, Antonina, Corallo, Francesco, Di Cara, Marcella, Bramanti, Placido, Sessa, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360296/
https://www.ncbi.nlm.nih.gov/pubmed/32664171
http://dx.doi.org/10.1097/MD.0000000000021212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360296/
https://www.ncbi.nlm.nih.gov/pubmed/32664171
http://dx.doi.org/10.1097/MD.0000000000021212

Ejemplares similares